Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000176 | nuclear exosome (RNase complex) | 3 | 2 |
GO:0000177 | cytoplasmic exosome (RNase complex) | 5 | 2 |
GO:0000178 | exosome (RNase complex) | 4 | 2 |
GO:0005654 | nucleoplasm | 2 | 2 |
GO:0005730 | nucleolus | 5 | 2 |
GO:0032991 | protein-containing complex | 1 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043228 | non-membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0140513 | nuclear protein-containing complex | 2 | 2 |
GO:1902494 | catalytic complex | 2 | 2 |
GO:1905354 | exoribonuclease complex | 3 | 2 |
Related structures:
AlphaFold database: E9ACA7
Term | Name | Level | Count |
---|---|---|---|
GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic | 8 | 2 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 7 | 2 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006396 | RNA processing | 6 | 2 |
GO:0006401 | RNA catabolic process | 5 | 2 |
GO:0006402 | mRNA catabolic process | 6 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009056 | catabolic process | 2 | 2 |
GO:0009057 | macromolecule catabolic process | 4 | 2 |
GO:0009892 | negative regulation of metabolic process | 4 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0010468 | regulation of gene expression | 5 | 2 |
GO:0010605 | negative regulation of macromolecule metabolic process | 5 | 2 |
GO:0010629 | negative regulation of gene expression | 6 | 2 |
GO:0016070 | RNA metabolic process | 5 | 2 |
GO:0016071 | mRNA metabolic process | 6 | 2 |
GO:0016072 | rRNA metabolic process | 7 | 2 |
GO:0016073 | snRNA metabolic process | 7 | 2 |
GO:0016074 | sno(s)RNA metabolic process | 7 | 2 |
GO:0016075 | rRNA catabolic process | 7 | 2 |
GO:0016180 | snRNA processing | 8 | 2 |
GO:0019222 | regulation of metabolic process | 3 | 2 |
GO:0019439 | aromatic compound catabolic process | 4 | 2 |
GO:0031123 | RNA 3'-end processing | 7 | 2 |
GO:0031126 | sno(s)RNA 3'-end processing | 9 | 2 |
GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' | 9 | 2 |
GO:0034470 | ncRNA processing | 7 | 2 |
GO:0034472 | snRNA 3'-end processing | 8 | 2 |
GO:0034475 | U4 snRNA 3'-end processing | 9 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0034655 | nucleobase-containing compound catabolic process | 4 | 2 |
GO:0034660 | ncRNA metabolic process | 6 | 2 |
GO:0034661 | ncRNA catabolic process | 6 | 2 |
GO:0043144 | sno(s)RNA processing | 8 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0043628 | regulatory ncRNA 3'-end processing | 8 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0044248 | cellular catabolic process | 3 | 2 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 2 |
GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 2 |
GO:0044270 | cellular nitrogen compound catabolic process | 4 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0046700 | heterocycle catabolic process | 4 | 2 |
GO:0048519 | negative regulation of biological process | 3 | 2 |
GO:0050789 | regulation of biological process | 2 | 2 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 2 |
GO:0065007 | biological regulation | 1 | 2 |
GO:0071025 | RNA surveillance | 6 | 2 |
GO:0071027 | nuclear RNA surveillance | 7 | 2 |
GO:0071028 | nuclear mRNA surveillance | 8 | 2 |
GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing | 10 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
GO:1901361 | organic cyclic compound catabolic process | 4 | 2 |
GO:1901575 | organic substance catabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 1 |
GO:0016787 | hydrolase activity | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 93 | 97 | PF00656 | 0.540 |
CLV_NRD_NRD_1 | 7 | 9 | PF00675 | 0.405 |
CLV_NRD_NRD_1 | 86 | 88 | PF00675 | 0.300 |
CLV_PCSK_KEX2_1 | 7 | 9 | PF00082 | 0.423 |
CLV_PCSK_SKI1_1 | 11 | 15 | PF00082 | 0.476 |
CLV_PCSK_SKI1_1 | 119 | 123 | PF00082 | 0.306 |
CLV_PCSK_SKI1_1 | 19 | 23 | PF00082 | 0.305 |
DEG_SPOP_SBC_1 | 232 | 236 | PF00917 | 0.636 |
DOC_MAPK_DCC_7 | 130 | 140 | PF00069 | 0.524 |
DOC_MAPK_gen_1 | 114 | 123 | PF00069 | 0.508 |
DOC_MAPK_gen_1 | 7 | 16 | PF00069 | 0.528 |
DOC_MAPK_MEF2A_6 | 119 | 128 | PF00069 | 0.480 |
DOC_PP4_FxxP_1 | 265 | 268 | PF00568 | 0.427 |
DOC_USP7_MATH_1 | 142 | 146 | PF00917 | 0.546 |
DOC_USP7_MATH_1 | 205 | 209 | PF00917 | 0.550 |
DOC_USP7_MATH_1 | 216 | 220 | PF00917 | 0.529 |
DOC_USP7_MATH_1 | 233 | 237 | PF00917 | 0.508 |
DOC_USP7_MATH_1 | 292 | 296 | PF00917 | 0.458 |
DOC_USP7_MATH_1 | 99 | 103 | PF00917 | 0.574 |
LIG_14-3-3_CanoR_1 | 155 | 159 | PF00244 | 0.432 |
LIG_14-3-3_CanoR_1 | 182 | 187 | PF00244 | 0.708 |
LIG_14-3-3_CanoR_1 | 256 | 265 | PF00244 | 0.279 |
LIG_14-3-3_CanoR_1 | 308 | 316 | PF00244 | 0.492 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.498 |
LIG_CtBP_PxDLS_1 | 239 | 243 | PF00389 | 0.526 |
LIG_FHA_1 | 57 | 63 | PF00498 | 0.535 |
LIG_FHA_1 | 93 | 99 | PF00498 | 0.558 |
LIG_FHA_2 | 10 | 16 | PF00498 | 0.460 |
LIG_FHA_2 | 201 | 207 | PF00498 | 0.362 |
LIG_FHA_2 | 25 | 31 | PF00498 | 0.410 |
LIG_FHA_2 | 91 | 97 | PF00498 | 0.509 |
LIG_LIR_Gen_1 | 194 | 202 | PF02991 | 0.493 |
LIG_LIR_Nem_3 | 194 | 199 | PF02991 | 0.542 |
LIG_NRBOX | 99 | 105 | PF00104 | 0.540 |
LIG_PCNA_yPIPBox_3 | 141 | 155 | PF02747 | 0.449 |
LIG_REV1ctd_RIR_1 | 314 | 322 | PF16727 | 0.397 |
LIG_SH2_CRK | 213 | 217 | PF00017 | 0.659 |
LIG_SH2_CRK | 255 | 259 | PF00017 | 0.441 |
LIG_SH2_NCK_1 | 213 | 217 | PF00017 | 0.659 |
LIG_SH2_STAP1 | 196 | 200 | PF00017 | 0.480 |
LIG_SH2_STAP1 | 299 | 303 | PF00017 | 0.491 |
LIG_SH2_STAP1 | 57 | 61 | PF00017 | 0.524 |
LIG_SH2_STAT5 | 198 | 201 | PF00017 | 0.460 |
LIG_SH2_STAT5 | 5 | 8 | PF00017 | 0.453 |
LIG_SH3_3 | 68 | 74 | PF00018 | 0.542 |
LIG_SUMO_SIM_anti_2 | 125 | 132 | PF11976 | 0.531 |
LIG_SUMO_SIM_par_1 | 120 | 125 | PF11976 | 0.499 |
LIG_SUMO_SIM_par_1 | 301 | 307 | PF11976 | 0.427 |
LIG_TRAF2_1 | 204 | 207 | PF00917 | 0.456 |
LIG_TRFH_1 | 198 | 202 | PF08558 | 0.479 |
LIG_WRC_WIRS_1 | 26 | 31 | PF05994 | 0.413 |
MOD_CK1_1 | 191 | 197 | PF00069 | 0.588 |
MOD_CK1_1 | 231 | 237 | PF00069 | 0.720 |
MOD_CK1_1 | 24 | 30 | PF00069 | 0.480 |
MOD_CK1_1 | 281 | 287 | PF00069 | 0.619 |
MOD_CK2_1 | 181 | 187 | PF00069 | 0.629 |
MOD_CK2_1 | 191 | 197 | PF00069 | 0.507 |
MOD_CK2_1 | 200 | 206 | PF00069 | 0.303 |
MOD_CK2_1 | 216 | 222 | PF00069 | 0.551 |
MOD_CK2_1 | 9 | 15 | PF00069 | 0.486 |
MOD_CK2_1 | 99 | 105 | PF00069 | 0.488 |
MOD_GlcNHglycan | 144 | 147 | PF01048 | 0.335 |
MOD_GlcNHglycan | 175 | 178 | PF01048 | 0.679 |
MOD_GlcNHglycan | 190 | 193 | PF01048 | 0.488 |
MOD_GlcNHglycan | 203 | 206 | PF01048 | 0.403 |
MOD_GlcNHglycan | 218 | 221 | PF01048 | 0.574 |
MOD_GlcNHglycan | 235 | 238 | PF01048 | 0.722 |
MOD_GlcNHglycan | 283 | 286 | PF01048 | 0.607 |
MOD_GlcNHglycan | 309 | 312 | PF01048 | 0.487 |
MOD_GSK3_1 | 182 | 189 | PF00069 | 0.660 |
MOD_GSK3_1 | 201 | 208 | PF00069 | 0.268 |
MOD_GSK3_1 | 21 | 28 | PF00069 | 0.423 |
MOD_GSK3_1 | 224 | 231 | PF00069 | 0.763 |
MOD_GSK3_1 | 99 | 106 | PF00069 | 0.517 |
MOD_NEK2_1 | 103 | 108 | PF00069 | 0.480 |
MOD_NEK2_1 | 263 | 268 | PF00069 | 0.353 |
MOD_NEK2_1 | 278 | 283 | PF00069 | 0.259 |
MOD_NEK2_1 | 29 | 34 | PF00069 | 0.459 |
MOD_PK_1 | 182 | 188 | PF00069 | 0.704 |
MOD_PKA_2 | 154 | 160 | PF00069 | 0.354 |
MOD_PKA_2 | 181 | 187 | PF00069 | 0.708 |
MOD_PKA_2 | 307 | 313 | PF00069 | 0.424 |
MOD_Plk_1 | 104 | 110 | PF00069 | 0.540 |
MOD_Plk_1 | 205 | 211 | PF00069 | 0.491 |
MOD_Plk_1 | 24 | 30 | PF00069 | 0.505 |
MOD_Plk_2-3 | 25 | 31 | PF00069 | 0.413 |
MOD_Plk_4 | 191 | 197 | PF00069 | 0.581 |
MOD_Plk_4 | 30 | 36 | PF00069 | 0.486 |
MOD_Plk_4 | 99 | 105 | PF00069 | 0.489 |
MOD_SUMO_rev_2 | 15 | 24 | PF00179 | 0.241 |
MOD_SUMO_rev_2 | 80 | 89 | PF00179 | 0.522 |
TRG_ENDOCYTIC_2 | 196 | 199 | PF00928 | 0.485 |
TRG_ENDOCYTIC_2 | 255 | 258 | PF00928 | 0.447 |
TRG_ENDOCYTIC_2 | 299 | 302 | PF00928 | 0.496 |
TRG_ER_diArg_1 | 6 | 8 | PF00400 | 0.369 |
TRG_Pf-PMV_PEXEL_1 | 81 | 85 | PF00026 | 0.340 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IIN2 | Leptomonas seymouri | 64% | 94% |
A0A0S4JHC4 | Bodo saltans | 35% | 100% |
A0A1X0NK34 | Trypanosomatidae | 39% | 100% |
A0A3R7MES5 | Trypanosoma rangeli | 37% | 100% |
A0A451EJG9 | Leishmania donovani | 92% | 100% |
A4HRM9 | Leishmania infantum | 91% | 100% |
C9ZIZ5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 100% |
E9AJJ5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |